Johnson & Johnson (NYSE:JNJ) opened the pharmaceutical earnings season on Tuesday by boosting its full-year sales forecast after posting stronger-than-expected first-quarter results. The ...

Anthony Karmelo walked out of jail on bond on Monday. He has been charged with first degree murder after he stabbed Austin Metcalf. Amid a racial debate over the stabbing of Texas teen Austin ...

Much has been written about the demise of the traditional pharmaceutical sales model and the “Complex Buying Environment” that now pervades within our industry. The reasons have been well docu ...

The pandemic’s first effects on pharma sales were swift and immediate, as lockdowns were put in place and doctors did everything they could to avoid unnecessary face-to-face contact with ...

Over that stretch, 11 different major pharmaceutical brands turned in double-digit sales increases, J&J said in an earnings presentation (PDF). J&J CEO broke a stalemate and facilitated the $14.6B ...

Core operating margin greater than 30.0% of total sales, which includes additional R&D expenses from anticipated ... the impact of pharmaceutical industry regulation and healthcare legislation ...

Founded in 1935 by Khwaja Abdul Ahmeid, Cipla operates through two segments: Pharmaceuticals and New Ventures. Cipla Limited specialises in developing medications, primarily treating respiratory ...

Its findings hold true today and leading pharma sales and commercial excellence leader Chris Costandi states: “Coaching helps the individual by giving them an opportunity and a platform to ...

This is an area where only ‘approved emails’ from pharma sales reps to HCPs have historically approached standard practice, with virtual e-detailing or eRep activities more likely to be still ...

In this article, Marty Nicholas provides us with three quick-win, pharma-specific Sales Force Effectiveness strategies that drive an immediate lift in sales performance. To many sales leaders ...

Artificial intelligence (AI) is reshaping the pharmaceutical industry, driving advances from drug discovery and clinical trial acceleration to manufacturing optimisation and commercialisation.

While women currently make up almost 50 per cent of the total pharmaceutical industry workforce, there is a “long way to go” before we see the leadership gender gap begin to close, said Seb.